Bill116th CongressFiled Dec 10, 2019Health
H.R. 5382
To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Dec 10, 2019)
This bill requires the federal government to create a mechanism through which insulin manufacturers may sell their products directly to consumers at current net prices.
What just happenedDec 11, 2019
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Fortenberry, Jeff [R-NE-1](R-NE)Sponsor
1committees4actions3subjects
- Introduced in HouseDec 10, 2019
- Dec 11, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Dec 10, 2019IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Dec 10, 2019IntroReferralIntro-H
Introduced in House
- Dec 10, 2019IntroReferral1000
Introduced in House